# Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy

> **NCT03115515** · NA · COMPLETED · sponsor: **Medstar Health Research Institute** · enrollment: 60 (actual)

## Conditions studied

- Pregnancy Related
- Thyroid

## Interventions

- **DRUG:** levothyroxine

## Key facts

- **NCT ID:** NCT03115515
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115515, "Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03115515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*